ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Pennsylvania » Geriatric Medicine

Top Geriatric Medicine Prescribers in Pennsylvania

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
PAUL MOYER M.D.

Geriatric Medicine

6,892

$356K

151
145 are 65+

17%
patients receiving schedule two controlled substances

Avg: 14%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 24%

$52
Average prescription price

Avg: $50

JOEL BETESH MD

Geriatric Medicine

3,175

$164K

208
169 are 65+

7%
patients receiving schedule two controlled substances

Avg: 14%

8%
patients receiving schedule three controlled substances

Avg: 6%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$52
Average prescription price

Avg: $50

WILLIAM ZIRKER MD

Geriatric Medicine

7,219

$372K

223
203 are 65+

13%
patients receiving schedule two controlled substances

Avg: 14%

0%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$52
Average prescription price

Avg: $50

CHINTANA SUANLARM MD

Geriatric Medicine

3,464

$178K

127
74 are 65+

32%
patients receiving schedule two controlled substances

Avg: 14%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$51
Average prescription price

Avg: $50

RUXANDRA JADIC MD

Geriatric Medicine

4,202

$216K

174
174 are 65+

13%
patients receiving schedule two controlled substances

Avg: 14%

12%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$51
Average prescription price

Avg: $50

RACHEL SHIPLEY M.D.

Geriatric Medicine

8,070

$413K

490
421 are 65+

9%
patients receiving schedule two controlled substances

Avg: 14%

9%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$51
Average prescription price

Avg: $50

MARY ANN FORCIEA MD

Geriatric Medicine

2,061

$105K

165
164 are 65+

19%
patients receiving schedule two controlled substances

Avg: 14%

7%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$51
Average prescription price

Avg: $50

LYNSEY BRANDT MD

Geriatric Medicine

3,297

$167K

217
214 are 65+

11%
patients receiving schedule two controlled substances

Avg: 14%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$51
Average prescription price

Avg: $50

CAROL SLOMPAK-PATTON MD

Geriatric Medicine

6,791

$339K

434
400 are 65+

4%
patients receiving schedule two controlled substances

Avg: 14%

4%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$50
Average prescription price

Avg: $50

BRUCE SILVER MD

Geriatric Medicine

4,916

$245K

180
171 are 65+

21%
patients receiving schedule two controlled substances

Avg: 14%

0%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 24%

$50
Average prescription price

Avg: $50

RICHARD GRANT MD

Geriatric Medicine

26,324

$1.31M

689
388 are 65+

9%
patients receiving schedule two controlled substances

Avg: 14%

7%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 24%

$50
Average prescription price

Avg: $50

UMESH GOLANI MD

Geriatric Medicine

22,762

$1.13M

629
477 are 65+

17%
patients receiving schedule two controlled substances

Avg: 14%

17%
patients receiving schedule three controlled substances

Avg: 6%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$50
Average prescription price

Avg: $50

DOROTHY CANDIB MD

Geriatric Medicine

7,265

$360K

235
234 are 65+

42%
patients receiving schedule two controlled substances

Avg: 14%

9%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$50
Average prescription price

Avg: $50

MARY MUSUKU M.D

Geriatric Medicine

5,549

$275K

257
198 are 65+

19%
patients receiving schedule two controlled substances

Avg: 14%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 24%

$50
Average prescription price

Avg: $50

IBIYONU LAWRENCE MD

Geriatric Medicine

3,858

$191K

194
141 are 65+

8%
patients receiving schedule two controlled substances

Avg: 14%

12%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$49
Average prescription price

Avg: $50

MONICA SETHI MD

Geriatric Medicine

1,993

$98K

117
89 are 65+

33%
patients receiving schedule two controlled substances

Avg: 14%

11%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$49
Average prescription price

Avg: $50

ZACHARY SIMPSON MD

Geriatric Medicine

25,361

$1.24M

498
489 are 65+

12%
patients receiving schedule two controlled substances

Avg: 14%

5%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 24%

$49
Average prescription price

Avg: $50

ANDREW ROSENZWEIG M.D.

Geriatric Medicine

3,657

$178K

174
170 are 65+

10%
patients receiving schedule two controlled substances

Avg: 14%

0%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 24%

$49
Average prescription price

Avg: $50

GARY BERNETT M.D.

Geriatric Medicine

3,757

$181K

72
72 are 65+

0%
patients receiving schedule two controlled substances

Avg: 14%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$48
Average prescription price

Avg: $50

SHADAB KALIM M.D.

Geriatric Medicine

3,980

$190K

260
92 are 65+

9%
patients receiving schedule two controlled substances

Avg: 14%

5%
patients receiving schedule three controlled substances

Avg: 6%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$48
Average prescription price

Avg: $50

FAINA CAPLAN MD

Geriatric Medicine

11,440

$544K

328
319 are 65+

12%
patients receiving schedule two controlled substances

Avg: 14%

4%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$48
Average prescription price

Avg: $50

CATHERINE GRUER MD

Geriatric Medicine

6,803

$320K

161
126 are 65+

32%
patients receiving schedule two controlled substances

Avg: 14%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$47
Average prescription price

Avg: $50

WARD BECKER M.D.

Geriatric Medicine

8,877

$415K

234
230 are 65+

18%
patients receiving schedule two controlled substances

Avg: 14%

9%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$47
Average prescription price

Avg: $50

HEIDI SYROPOULOS M.D.

Geriatric Medicine

2,180

$101K

301
209 are 65+

4%
patients receiving schedule two controlled substances

Avg: 14%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 24%

$47
Average prescription price

Avg: $50

NAMITA AHUJA MD

Geriatric Medicine

6,440

$299K

220
212 are 65+

20%
patients receiving schedule two controlled substances

Avg: 14%

14%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$46
Average prescription price

Avg: $50

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank